These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1728277)

  • 21. Cefixime in the treatment of upper respiratory tract infections and otitis media.
    de Lalla F
    Chemotherapy; 1998 Sep; 44 Suppl 1():19-23. PubMed ID: 9797419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of ceftibuten compared with amoxicillin for otitis media with effusion in infants and children.
    Mandel EM; Casselbrant ML; Kurs-Lasky M; Bluestone CD
    Pediatr Infect Dis J; 1996 May; 15(5):409-14. PubMed ID: 8724062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumococcal bacteremia during oral treatment with cefixime for otitis media.
    Ottolini MG; Ascher DP; Cieslak TJ; Modica-Lucero S
    Pediatr Infect Dis J; 1991 Jun; 10(6):467-8. PubMed ID: 1852543
    [No Abstract]   [Full Text] [Related]  

  • 24. Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children.
    Kenna MA; Bluestone CD; Fall P; Stephenson J; Kurs-Lasky M; Wucher FP; Blatter MM; Reisinger KS
    Pediatr Infect Dis J; 1987 Oct; 6(10):992-6. PubMed ID: 3696840
    [No Abstract]   [Full Text] [Related]  

  • 25. Hydrolase activity in middle ear effusions. Effect of antibiotic therapy.
    Diven WF; Doyle WJ; Vietmeier B
    Arch Otolaryngol Head Neck Surg; 1988 Jan; 114(1):52-5. PubMed ID: 2825732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and treatment of otitis media with effusion in children in the first year of primary school.
    Marchisio P; Principi N; Passali D; Salpietro DC; Boschi G; Chetrì G; Caramia G; Longhi R; Reali E; Meloni G; De Santis A; Sacher B; Cupido G
    Acta Otolaryngol; 1998 Jul; 118(4):557-62. PubMed ID: 9726683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport characteristics of ceftibuten, cefixime and cephalexin across human jejunal brush-border membrane.
    Sugawara M; Iseki K; Miyazaki K; Shiroto H; Kondo Y; Uchino J
    J Pharm Pharmacol; 1991 Dec; 43(12):882-4. PubMed ID: 1687593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptococcus pneumoniae resistant to penicillin: incidence and potential therapeutic options.
    Rodriguez WJ; Schwartz RH; Akram S; Khan WN
    Laryngoscope; 1995 Mar; 105(3 Pt 1):300-4. PubMed ID: 7877420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Dabernat H; Geslin P; Megraud F; Bégué P; Boulesteix J; Dubreuil C; de La Roque F; Trinh A; Scheimberg A
    J Antimicrob Chemother; 1998 Feb; 41(2):253-8. PubMed ID: 9533468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
    Dagan R; Abramson O; Leibovitz E; Lang R; Goshen S; Greenberg D; Yagupsky P; Leiberman A; Fliss DM
    Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of cefixime in the treatment of otitis media in infants and children.
    Bluestone CD
    Pediatr Infect Dis J; 1993 Jan; 12(1):75-82. PubMed ID: 8417430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tympanometry in children with treated acute otitis media.
    Wheeler MT
    Lancet; 1986 Mar; 1(8480):529-32. PubMed ID: 2869263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
    Arguedas A; Dagan R; Leibovitz E; Hoberman A; Pichichero M; Paris M
    Pediatr Infect Dis J; 2006 Mar; 25(3):211-8. PubMed ID: 16511382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single dose of betamethasone in combined medical treatment of secretory otitis media.
    Hemlin C; Carenfelt C; Papatziamos G
    Ann Otol Rhinol Laryngol; 1997 May; 106(5):359-63. PubMed ID: 9153098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Third generation oral cephalosporins: comparative in vitro kinetics.
    Speciale A; Blandino G; Nicoletti G
    J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing outcome in children treated with antibiotics for acute otitis media.
    Berman S; Roark R
    Pediatr Infect Dis J; 1993 Jan; 12(1):20-4. PubMed ID: 8417420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of pneumococcal nasopharyngeal carriage in children with nonresponsive acute otitis media treated with two regimens of intramuscular ceftriaxone.
    Haiman T; Leibovitz E; Piglansky L; Press J; Yagupsky P; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2002 Jul; 21(7):642-7. PubMed ID: 12237596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefixime compared with amoxicillin for treatment of acute otitis media.
    Johnson CE; Carlin SA; Super DM; Rehmus JM; Roberts DG; Christopher NC; Whitwell JK; Shurin PA
    J Pediatr; 1991 Jul; 119(1 Pt 1):117-22. PubMed ID: 1906097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of acute otitis media caused by resistant pneumococci in infants.
    Roger G; Carles P; Pangon B; Thien HV; Polonovski JM; Begue P; Garabedian EN
    Pediatr Infect Dis J; 1998 Jul; 17(7):631-8. PubMed ID: 9686731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.